Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3 (vol 21, pg 290, 2014)

被引：0
|
作者：
Gan, R.
Yang, Y.
Yang, X.
Zhao, L.
Lu, J.
Meng, Q. H.
机构：
[1] Wenzhou Medical University School of Laboratory Medicine and Life Sciences,Key Laboratory of Laboratory Medicine
[2] Ministry of Education,Department of Laboratory Medicine
[3] Zhejiang Provincial Key Laboratory of Medical Genetics,undefined
[4] The University of Texas MD Anderson Cancer,undefined
来源：
CANCER GENE THERAPY | 2023年 / 30卷 / 11期
关键词：
D O I：
10.1038/s41417-023-00672-5
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1582 / 1582
页数：1
相关论文
共 50 条
  • [1] Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3
    Gan, R.
    Yang, Y.
    Yang, X.
    Zhao, L.
    Lu, J.
    Meng, Q. H.
    CANCER GENE THERAPY, 2014, 21 (07) : 290 - 296
  • [2] Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3
    R Gan
    Y Yang
    X Yang
    L Zhao
    J Lu
    Q H Meng
    Cancer Gene Therapy, 2014, 21 : 290 - 296
  • [3] Correction to: Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3
    R. Gan
    Y. Yang
    X. Yang
    L. Zhao
    J. Lu
    Q. H. Meng
    Cancer Gene Therapy, 2023, 30 : 1582 - 1582
  • [4] Downregulation of miR-221 enhances the sensitivity of human oral squamous cell carcinoma cells to Adriamycin through upregulation of TIMP3 expression
    Chen, Dan
    Yan, Wangxiang
    Liu, Zhiguo
    Zhang, Zhaoqiang
    Zhu, Lijun
    Liu, Weidong
    Ding, Xueqiang
    Wang, Anxun
    Chen, Yu
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 77 : 72 - 78
  • [5] Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells
    Wei, Yifang
    Lai, Xiaofeng
    Yu, Shentong
    Chen, Suning
    Ma, Yongzheng
    Zhang, Yuan
    Li, Huichen
    Zhu, Xingmei
    Yao, Libo
    Zhang, Jian
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 147 (02) : 423 - 431
  • [6] Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells
    Yifang Wei
    Xiaofeng Lai
    Shentong Yu
    Suning Chen
    Yongzheng Ma
    Yuan Zhang
    Huichen Li
    Xingmei Zhu
    Libo Yao
    Jian Zhang
    Breast Cancer Research and Treatment, 2014, 147 : 423 - 431
  • [7] RETRACTION: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation (Retraction of Vol 16, Pg 498, 2009)
    Garofalo, Michela
    Di Leva, Gianpiero
    Romano, Giulia
    Nuovo, Gerard
    Suh, Sung-Suk
    Ngankeu, Apollinaire
    Taccioli, Cristian
    Pichiorri, Flavia
    Alder, Hansjuerg
    Secchiero, Paola
    Gasparini, Pierluigi
    Gonelli, Arianna
    Costinean, Stefan
    Acunzo, Mario
    Condorelli, Gerolama
    Croce, Carlo Maria
    CANCER CELL, 2022, 40 (11) : 1440 - 1440
  • [8] Survival relevance of tamoxifen sensitivity-related microRNAs, miR-342 and miR-221/222, in breast cancer patients
    Young, Jessica S.
    Kawaguchi, Tsutomu
    Yan, Li
    Qi, Qianya
    Liu, Song
    Takabe, Kazuaki
    CANCER RESEARCH, 2018, 78 (04)
  • [9] Changes in miR-221/222 Levels in Invasive and In Situ Carcinomas of the Breast: Differences in Association with Estrogen Receptor and TIMP3 Expression Levels
    Nina Petrovic
    Radoslav Davidovic
    Snezana Jovanovic-Cupic
    Milena Krajnovic
    Silvana Lukic
    Milan Petrovic
    Jelena Roganovic
    Molecular Diagnosis & Therapy, 2016, 20 : 603 - 615
  • [10] Changes in miR-221/222 Levels in Invasive and In Situ Carcinomas of the Breast: Differences in Association with Estrogen Receptor and TIMP3 Expression Levels
    Petrovic, Nina
    Davidovic, Radoslav
    Jovanovic-Cupic, Snezana
    Krajnovic, Milena
    Lukic, Silvana
    Petrovic, Milan
    Roganovic, Jelena
    MOLECULAR DIAGNOSIS & THERAPY, 2016, 20 (06) : 603 - 615
12345